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Abstract:  The  purpose  of  this  study  was  to  evaluate  the  antioxidant  nature  of  tea 
polyphenol on S180 cells induced liver cancer in mice. In the present study, hepatocellular 
carcinoma was induced by tumor transplantation of liver in situ. The antitumor activity of 
tea  polyphenol  has  been  determined  in  vivo  in  hepatocellular  carcinoma  mice  after 
treatment  of  drug  (50,  100,  150  mg/kg  body  weight)  by  gavage  for  20  days.  Results 
showed  that  a  significant  increase  in  serum  aspartate  transaminase  (AST),  alkaline 
phosphatase  (ALP),  alanine  aminotransfere  (ALT),  malondialdehyde  (MDA)  level, 
decrease in serum white blood cells (WBC), serum total protein (TP), albumin (ALB), A/G, 
tumor necrosis factor-α (TNF-α) and interferon-gamma (IFN-γ), liver reduced glutathione 
(GSH)  levels  were  observed.  In  addition,  the  levels  of  enzymic  and  non-enzymic 
antioxidants were decreased when subjected to S180 cells induction. These altered enzyme 
levels  were  ameliorated  significantly  by  administration  of  tea  polyphenol  at  the 
concentration of 50, 100, 150 mg/kg body weight in drug-treated animals. These results 
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indicate that the protective effect of tea polyphenol was associated with inhibition of MDA 
induced by S180 cells and to maintain the antioxidant enzyme levels. 
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1. Introduction  
Hepatocellular carcinoma (HCC), a leading cause of death in China and many Asian countries, is 
difficult to treat because of early progression and metastasis. It is well known that angiogenesis is 
essential for the survival, growth, and metastasis of tumor cells [1–5]. Hepatitis B (HBV) and Hepatitis 
C virus (HCV) are the risk factors attributed to 80% of HCC cases globally [6]. Cirrhosis, radiation, 
free radicals, genetic changes, metabolic disorder and exposure to certain chemical carcinogens such as 
aflatoxin,  ethionine,  diethylnitrosamine  (DEN)  and  2-acetylaminofluorene  (AAF)  have  also  been 
implicated in the pathogenesis of hepatocarcinoma [7–10]. 
Several human chronic disease states including cancer have been associated with oxidative stress 
produced through either an increased free radical generation and/or a decreased antioxidant level in the 
target  cells  and  tissues  [11–14].  A  role  for  reactive  oxygen  radicals  in  the  etiology  of  cancer  is 
supported by epidemiologic studies. Specifically these epidemiologic studies illustrated the protective 
role for antioxidants against cancer development [15–17]. Continuous production of oxygen radicals 
leads to the formation of covalent bond adduct with DNA nucleic acid, which will subsequently result 
in mutagenicity. Endogenous antioxidant enzymes such as superoxide dismutase (SOD), glutathione 
peroxidase (GSH-Px) and catalase (CAT) have been reported to reduce the free radical formation and 
prevent oxidative damage [18,19]. 
Herbal medicines derived from plant extracts are being increasingly utilized to treat a wide variety 
of clinical disease [20]. More attention has been paid to the protective effects of natural antioxidants 
against drug-induced toxicities especially whenever free radical generation is involved [21,22]. Green 
tea and its constituent catechins are best known for their antioxidant properties, which has led to their 
evaluation in a number of diseases associated with reactive oxygen species (ROS), such as cancer, 
cardiovascular and neurodegenerative diseases. Several epidemiological studies as well as studies in 
animal models have shown that green tea can afford protection against various cancers such as those of 
the skin, breast, prostate and lung [23]. In addition to the cancer chemopreventive properties, green tea 
and EGCG have been shown to be anti-angiogenic (prevention of tumor blood vessel growth) [24,25] 
and anti-mutagenic [26,27]. Other health benefits attributed to green tea include antibacterial [28], 
anti-HIV [29], anti-aging [30] and anti-inflammatory activity [31]. 
In  the  present  study,  effect  of  tea  polyphenol  on  oxidative  injury  in  hepatocarcinoma  mice  
was evaluated. Int. J. Mol. Sci. 2012, 13  5573 
 
 
2. Results 
2.1. Inhibitory Effects on the Tumor-Bearing Mice S180 Model by Tea Polyphenol  
In an in vitro study, we found that tea polyphenol (20–200 μg/mL) could significantly inhibit S180 
cell growth. Moreover, the inhibition rate was increased with increasing content of tea polyphenol  
(20–200 μg/mL). 
There  was  no  statistical  significance  in  the  mice’s  body  weights  (beginning  and  end)  between 
groups (P > 0.01, Table 1). Results showed that tea polyphenol had notable inhibitory effects on the  
sarcoma-loaded  mice  S180  model,  which  led  to  a  depressed  trend  of  tumor  weights.  The  tumor 
inhibition rate of tea polyphenol at high dose, intermediate dose and low dose groups was 64, 48 and 
28%, respectively (Table 2). 
Table 1. High Performance Liquid Chromatography analysis of tea polyphenol. 
Sample  Chemical Components  Retention Time (min)  Peak Area  Content (mg/g) 
Tea 
polyphenol 
GA  4.363  441,213.5  8.05 
EGC  11.984  216,448.9  52.85 
C  14.705  83,710.41  6.51 
EC  17.390  283,894.6  22.63 
EGCG  17.807  2,378,683  88.87 
ECG  23.089  2,110,191  65.09 
catechin  -  -  235.94 
Table 2. Inhibitory effects on the tumor-bearing mice S180 model by tea polyphenol. 
Group  Body Weight (g)  Tumour Weight 
(g) 
Inhibition Rate 
(%)  Begin  End 
I  21.42 ±  1.76  27.46 ±  1.63  -  - 
II  21.53 ±  1.59  27.22 ±  1.72  -  - 
III  21.85 ±  1.88  26.98 ±  2.07  0.25 ±  0.01  - 
IV  20.97 ±  1.37  26.83 ±  2.14  0.18 ±  0.01  28 
V  22.07 ±  1.59  26.79 ±  1.99  0.13 ±  0.02  48 
VI  21.68 ±  1.60  27.15 ±  1.94  0.09 ±  0.01  64 
2.2. Effect of Tea Polyphenol on Serum AST, ALT and ALP Activities 
Table 3 shows that serum AST, ALT and ALP activities in hepatocarcinoma control group (III) 
were  significantly  higher  than  those  in  normal  control  (group  I).  Compared  with  normal  control  
(group I), administration of tea polyphenol (150 mg/kg body weight) decreased serum AST, ALT and 
ALP  activities  in  group  II,  but  there  was  no  statistical  difference  in  serum  ALT  and  ALP. 
Administration of tea polyphenol (50, 100, 150 mg/kg body weight) dose-dependently significantly 
decreased  serum  AST,  ALT  and  ALP  activities  in  group  IV,  V  and  VI  when  compared  to 
hepatocarcinoma control group (III). Int. J. Mol. Sci. 2012, 13  5574 
 
 
Table 3. Effect of tea polyphenol on serum serum aspartate transaminase (AST), alanine 
aminotransfere (ALT) and alkaline phosphatase (ALP) activities. 
Group  AST (U/L)  ALP (U/L)  ALT (U/L) 
I  248.47 ±  13.86  114.18 ±  8.65  77.38 ±  3.76 
II  225.91 ±  17.11 
a  108.95 ±  9.37  70.28 ±  4.71 
III  307.21 ±  21.65 
b  134.26 ±  9.04 
b  94.18 ±  4.88 
b 
IV  278.41 ±  16.37 
d  125.03 ±  6.83 
c  88.02 ±  3.97 
c 
V  266.58 ±  18.38 
d  121.55 ±  7.93 
c  82.15 ±  4.17 
d 
VI  259.03 ±  19.47 
d  117.03 ±  9.03 
d  79.41 ±  2.86 
d 
a P < 0.05; 
b P < 0.01, compared with group I; 
c P < 0.05; 
d P < 0.01, compared with group III. 
2.3. Effect of Tea polyphenol on Serum WBC, TP, ALB and A/G 
Table 4 shows that serum WBC, TP, ALB and A/G in hepatocarcinoma control group (III) were 
significantly lower than those in normal control (group I). Although administration of tea polyphenol 
(150 mg/kg body weight) significantly increased serum WBC, and TP in group II when compared to 
normal control group (I), the decrease in serum ALB and A/G was not significant. Administration of 
tea polyphenol  (50, 100, 150 mg/kg body  weight) dose-dependently significantly increased serum 
WBC, TP, ALB and A/G in group IV, V and VI when compared to hepatocarcinoma control group (III). 
Table 4. Effect of tea polyphenol on serum white blood cells (WBC), total protein (TP), 
albumin (ALB) and A/G. 
Group  WBC (× 10
9/L)  TP (g/L)  ALB (g/L)  A/G 
I  23.05 ±  1.32  59.52 ±  1.86  33.41 ±  1.42  1.59 ±  0.09 
  24.91 ±  1.95 
a  61.02 ±  2.93 
a  34.24 ±  1.66  1.63 ±  0.11 
II  17.31 ±  1.11 
b  55.27 ±  1.95 
b  31.54 ±  1.76 
b  1.09 ±  0.1 
b 
III  19.33 ±  1.43 
c  57.21 ±  1.78 
c  31.95 ±  1.48  1.15 ±  0.08  
IV  21.49 ±  1.76 
c  58.72 ±  2.31 
c  32.41 ±  1.33  1.24 ±  0.09 
c 
V  22.42 ±  1.28 
d  58.83 ±  2.41 
c  32.77 ±  1.28 
c  1.44 ±  1.05 
d 
a P < 0.01; 
b P < 0.01, compared with group I; 
c P < 0.05; 
d P < 0.01, compared with group III. 
2.4. Effect of Tea Polyphenol on Serum TNF-α and IFN-γ 
Table 5 shows the effect of tea polyphenol on serum TNF-α and  IFN-γ in  experimental mice. 
Results revealed a significant decrease in serum TNF-α and IFN-γ levels of hepatocarcinoma control 
group (III) compared with the normal control group (I). Administration of tea polyphenol (150 mg/kg 
body weight) significantly increased serum TNF-α and IFN-γ levels in group II when compared to 
normal  control  group  (I).  Administration  of  tea  polyphenol  (50,  100,  150  mg/kg  body  weight)  
dose-dependently significantly increased serum TNF-α and IFN-γ levels in group IV, V and VI when 
compared to hepatocarcinoma control group (III). Int. J. Mol. Sci. 2012, 13  5575 
 
 
Table  5.  Effect  of  tea  polyphenol  on  serum  tumor  necrosis  factor-alpha  (TNF-α)  and 
Interferon-gamma (IFN-γ). 
Group  TNF-α (pg/mL)  IFN-γ (pg/mL) 
I  839.42 ±  32.18  505.37 ±  21.53 
II  873.67 ±  38.63 
b  518.09 ±  32.85 
III  401.65 ±  18.39 
b  251.73 ±  16.31 
b 
IV  548.29 ±  20.61 
d  332.84 ±  11.66 
d 
V  648.11 ±  22.17 
d  428.91 ±  19.06 
d 
VI  782.61 ±  19.62 
d  489.74 ±  21.64 
d 
b P < 0.01, compared with group I; 
d P < 0.01, compared with group III. 
2.5. Effect of Tea Polyphenol on Liver MDA and GSH 
Liver  MDA  concentration  was  significantly  enhanced  in  hepatocarcinoma  control  group  (III), 
whereas  GSH  level  was  markedly  decreased  compared  to  normal  control  group  (I)  (Table  6). 
Administration of tea polyphenol (150 mg/kg body weight) produced a significant decrease in liver 
MDA and increase in GSH level of group II mice in comparison with normal control group (I). The 
administration of tea polyphenol (50, 100, 150 mg/kg body weight) produced a significant decrease in 
liver MDA and increase in GSH level of group IV, V and VI mice. The decrease or increase was 
observed  to  be  dose-dependent  as  a  greater  decrease  or  increase  was  observed  in  mice  receiving  
150 mg/kg tea polyphenol compared to those administered 100, 50 mg/kg tea polyphenol (Table 6). 
Table 6. Effect of tea polyphenol on liver malondialdehyde (MDA) and glutathione (GSH). 
Group  MDA (nmol/mg prot)  GSH (nmol/mg) 
I  2.76 ±  0.13  63.17 ±  3.11 
II  1.59 ±  0.18 
b  86.64 ±  6.53 
b 
III  8.94 ±  0.42 
b  34.28 ±  1.53 
b 
IV  5.37 ±  0.17 
d  48.29 ±  1.85 
d 
V  4.48 ±  0.19 
d  56.03 ±  2.31 
d 
VI  3.51 ±  0.18 
d  60.41 ±  2.65 
d 
b P < 0.01, compared with group I; 
d P < 0.01, compared with group III. 
2.6. Effect of Tea Polyphenol on Liver SOD, CAT, GSH-Px and GR Activities 
Activities of liver SOD, CAT, GSH-Px and GR were significantly enhanced in group (II) compared 
to normal control group (I). Activities of liver SOD, CAT, GSH-Px and GR were significantly reduced 
in hepatocarcinoma control group (III) compared to normal control group (I). Administration of tea 
polyphenol at 50, 100, 150 mg/kg body weight dose-dependently significantly enhanced liver SOD, 
CAT, GSH-Px and GR activities in group IV, V and VI mice compared to hepatocarcinoma control 
group (III) (Table 7). Int. J. Mol. Sci. 2012, 13  5576 
 
 
Table 7. Effect of tea polyphenol on liver superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GSH-Px) and GR activities. 
Group  SOD (U/mg prot)  CAT (U/mg prot)  GSH-Px (U/mg prot)  GR (U/mg prot) 
I  362.81 ±  11.43  54.19 ±  2.06  48.22 ±  1.63  33.15 ±  1.09 
II  414.59 ±  15.22 
b  71.43 ±  3.08 
b  69.27 ±  2.25 
b  49.54 ±  1.65 
b 
III  148.25 ±  10.63 
b  23.18 ±  1.11 
b  20.75 ±  1.33 
b  14.28 ±  1.21 
b 
IV  195.39 ±  12.64 
d  37.08 ±  1.74 
d  33.15 ±  1.58 
d  21.14 ±  1.31 
d 
V  257.31 ±  15.03 
d  42.61 ±  2.31 
d  39.92 ±  1.76 
d  27.05 ±  1.48 
d 
VI  342.08 ±  17.22 
d  51.29 ±  2.65 
d  48.13 ±  1.92 
d  31.96 ±  1.39 
d 
b P < 0.01, compared with group I; 
d P < 0.01, compared with group III. 
3. Discussion 
In this study, we demonstrated that the implantation with S180 sarcoma to mice lead to a marked 
elevation in the levels of serum AST, ALT and ALP which is indicative of hepatocellular damage, as 
previously reported [32]. This elevation could potentially be attributed to the release of these enzymes 
from  the  cytoplasm  into  the  blood  circulation  after  rupture  of  the  plasma  membrane  and  cellular 
damage. Serum AST, ALT and ALP are biomarkers in the diagnosis of hepatic damage because they 
are  released  into  the  circulation  after  cellular  damage  [33].  Administration  of  tea  polyphenol 
significantly reduced the activity of liver enzymes in blood of hepatocarcinoma mice (group III). Due 
to its ability to reduce free radical-induced oxidative damage in the liver, tea polyphenol has been 
shown to decrease liver enzymes in serum and prevent liver damage of rats with liver fibrosis [34]. Tea 
polyphenol  prevents  liver  damage  by  maintaining  the  integrity  of  the  plasma  membrane,  thereby 
suppressing the leakage of enzymes. 
There are several different types of white cells in the blood in differing amounts. They all play a 
part in the immune response. A low white blood cell count (leukopenia) leaves your body more open 
to infection. Moreover, if an infection does develop, your body may be unable to fight it off. This is the 
response of the body to infection, or anything else the body recognizes as “foreign”. These blood cells 
can be made very quickly and generally have a short life. Some only live for a few hours, others for a 
few days [35]. Increased TP indicates dehydration or blood cancer, bone marrow cancer; decreases 
indicate  malnutrition,  poor  digestion,  liver  or  kidney  disease,  bleeding  or  burns  [36,37].  ALB  is 
produced by the liver, reduced levels of this protein can point to chronic liver or kidney disease, or 
parasitic infections such as hookworm. High levels indicate dehydration and loss of protein [38,39].  
In the present study, serum WBC, TP, ALB and A/G in hepatocarcinoma control group (III) were 
significantly  lower  than  those  in  normal  control  (group  I).  Increases  in  TP,  A/G,  albumin  were 
observed in mice implanted with S180 sarcoma (group III), and the degrees of change were big, and 
related toxicological changes were evident. Administration of tea polyphenol (50, 100, 150 mg/kg 
body weight) dose-dependently significantly increased serum WBC, TP, ALB and A/G in group IV, V 
and VI when compared to hepatocarcinoma control group (III). This indicated that tea polyphenol can 
improve immunity function in hepatocarcinoma mice. 
Tumor necrosis factor (TNF, cachexin or cachectin formerly known as tumor necrosis factor-alpha 
or TNF-α) is a cytokine involved in systemic inflammation and is a member of a group of cytokines 
that stimulate the acute phase reaction. It is produced chiefly by activated macrophages, although it can Int. J. Mol. Sci. 2012, 13  5577 
 
 
be produced by other cell types as well. The primary role of TNF is in the regulation of immune cells. 
TNF, being an endogenous pyrogen, is able to induce fever, to induce apoptotic cell death, to induce 
sepsis  (through  IL1  &  IL6  production),  to  induce  cachexia,  induce  inflammation,  and  to  inhibit 
tumorigenesis and viral replication [40,41]. Most scholars now agree that TNF and IFN are related to 
liver damage. Furthermore, TNF-α increases the susceptibility of liver endothelial cells to Fas-mediated 
apoptosis [42]. Interferon-gamma (IFN-γ) is a dimerized soluble cytokine that is the only member of 
the type II class of interferons [43]. This interferon was originally called macrophage-activating factor, 
a term now used to describe a larger family of proteins to which IFN-γ belongs. A significant decrease 
in serum TNF-α and IFN-γ levels were observed in liver cancer control group (group III), suggesting 
that decreased serum TNF-α and IFN-γ levels was an important marker of liver cancer. Administration 
of tea polyphenol increased serum TNF-α and IFN-γ levels in mice implanted with S180 sarcoma 
(group IV–VI). 
One strong mechanistic link between chronic inflammation and cancer is through the increased 
production of free radicals at the site of inflammation and the resulting molecular changes, which 
include lipid peroxidation and oxidative DNA damage [44]. Indeed, markers of DNA damage, such as 
8-hydroxydeoxyguanosine (8-OHdG), and lipid peroxidation, such as 4-hydroxynonenal (HNE) and 
malondialdehyde (MDA), are commonly elevated in liver of patients with chronic hepatitis C virus 
infection and correlate well with the degree of viral infection and inflammation, known risk factors for 
Hepatocellular carcinoma [45]. Level of liver MDA was markedly increased, whereas activities of 
liver SOD, CAT, GSH-Px and GR were significantly reduced in mice implanted with S180 sarcoma 
(group III). This suggested that oxidative injury occurred in hepatocellular carcinoma animals. 
It is well known that inflammation is one of the biological responses driven by oxidative stress. 
Modulation of oxidative damage as well as inflammation protect against hepatocarcinogenesis. It has 
been shown that resveratrol, a compound present in grapes and red wine, has potent antioxidant [46] 
and  anti-inflammatory  [47]  properties,  which  might  play  an  important  role  in  protecting  the  liver 
against carcinogen-induced neoplasia. Recently, it was reported that resveratrol significantly prevents 
diethylnitrosamine (DENA)-induced liver tumorigenesis in rats [48]. Administration of tea polyphenol 
at 50, 100, 150 mg/kg body weight dose-dependently significantly enhanced liver SOD, CAT, GSH-Px 
and GR activities in experimental mice (group IV–VI). These results suggested that oxidative injury 
was related to hepatocellular carcinoma development, and tea polyphenol played its antitumor activity 
partly by decreasing oxidative injury and increasing antioxidant enzymes activity. 
4. Experimental Section 
4.1. Material 
Tea polyphenol was purchased from Hangzhou HeTian TianBao Biotechnology Ltd. Its chemical 
composition was examined using HPLC (Table 1 and Figure 1).  Int. J. Mol. Sci. 2012, 13  5578 
 
 
Figure 1. Chemical composition of tea polyphenol. 
 
4.2. Animals 
C57BL/6J mice, aged 6–8 weeks and weighing 20–22 g, obtained from the microbiology Institute  
of Zhongshan University (Guangzhou, China), were used throughout the study. The animals  were 
supplied with standard mouse pellet diet and water ad libitum. 
4.3. Experimental Design 
The effect of the tea polyphenol on tumor growth was estimated by evaluating body weight, tumor 
weight, and percentage of tumor inhibition. S180 tumor cell line was originally obtained from  the 
microbiology Institute of Zhongshan University, and maintained as the ascites form by serial passages 
intraperitoneally in C57BL/6J mice. For solid tumor development, 0.2 mL of S180 cell suspension  
(2 ×  10
7 cells/mL) was inoculated subcutaneously into right armpits of mice under sterile condition. 
When tumor size was 1 cm, tumor tissues were removed and cut into 2 mm ×  1 mm tumor mass. Then, 
mice were anesthetized and the abdomen was incised. The liver was exposed, and a hole was made in 
the left lobe of the liver by straight ophthalmic forceps (3 mm). Then, these tumor masses were placed 
into  the  holes  in  the  mice  livers.  The  mice  were  divided  into  five  random  groups  (10  in  each):  
S180-bearing control, normal control, and three tea polyphenol treatments (50, 100, 150 mg/kg body 
weight for group III, IV and V). Test doses were decided on the basis of findings from preliminary 
studies. Body weight of animals was recorded before the experiment. Tea polyphenol were orally 
administrated by gavage daily for 20 days. Normal control (group I) and S180-bearing control groups (II) 
received the same volume of normal saline. On the 20th day, all animals were executed. Their body 
and tumor weights were obtained and documented. Finally, the tumor inhibition rate was calculated. 
4.4. Biochemical Analysis 
AST, ALT, ALP, TNF-α, IFN-γ were measured with commercially available Kits. 
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White blood cell (WBC) count was measured using a hematological autoanalyzer (Advia 120E, 
Bayer,  Newbury,  Berkshire,  UK).  Blood  collected  for  serum  biochemistry  was  untreated  and 
centrifuged at 3000 rpm for 10 min. The serum obtained was examined for the following parameters 
using a biochemistry autoanalyzer (Hitachi 7060, Tokyo, Japan): total protein (TP), albumin (ALB), 
A/G ratio. 
Liver  MDA  concentration  was  determined  by  using  the  method  described  by  Draper  and  
Hadley [49,50] based on TBA reactivity. Briefly, 2.5 mL of 10% trichloracetic acid and 0.5 mL of 
homogenate were added into tubes and mixed. After incubating for 15 min at 90 ° C and cooling with 
cold water the mixture was centrifuged at 3000 rpm for 10 min. Two milliliters of supernatant were 
taken and 1ml of 0.675% TBA was added. The tubes were sealed and incubated at 90 ° C for 15 min 
and then cooled to room temperature. The optical density was measured at 532 nm by a spectrophotometer. 
Determination  of  reduced  glutathione  level  (GSH)  in  liver  was  carried  out  according  to  the 
previously  described  colorimetric  method  [51].  This  method  depends  on  the  reaction  of  reduced 
glutathione with 5,5-dithiobis, 2-(nitrobenzoic acid) that can be measured colorimetrically. The yellow 
color developed was measured at 412 nm against a blank reagent.  
Superoxide dismutase (SOD) activity in liver homogenate was determined according to the method 
of Minami and Yoshikawa [52]. This method is based on the generation of superoxide anions by 
pyrogallol autoxidation, detection of generated superoxide anions by nitro blue tetrazolium (NBT) 
formazan color development and measurement of the amount of generated superoxide anions scavenged 
by SOD (the inhibitory level of formazan color development). The homogenate was centrifuged at 
105,000 g for 15 min at 4 ° C. To 0.25 mL of supernatant, 0.5 mL of tris cacodylic buffer, 0.1 mL of 
16% triton x-100 and 0.25 mL NBT were added. The reaction was started by the addition of 0.01 mL 
diluted pyrogallol. Incubation was maintained for 5 min at 37 ° C. The reaction was stopped by the 
addition  of  0.3  mL  of  2  M  formic  acid.  The  formazan  color  developed  was  determined 
spectrophotometrically (Spectronic 501, Shimadzu). 
Catalase activity of tissues was measured by the method of Aebi [53]. To a cuvette containing  
1.9 mL of 50 mmol phosphate buffer (pH 7.0), the appropriate dilution of tissue supernatant was added. 
The final volume of the mixture was made up to 2 mL by adding additional buffer solution. The 
reaction  was  started  by  the  addition  of  1.0  mL  of  freshly  prepared  30  mmol  H2O2.  The  rate  of 
decomposition of H2O2 was measured spectrophotometrically at 240 nm. 
The method of Lawrence and Burk [54] as described by Mantha et al. [55] was used to measure 
GSH-Px activity. The assay mixture consisted of 2.0 mL of 75 mmol phosphate buffer (pH 7.0), 50 μL 
of 60 mmol glutathione, 0.1 mL of 30 units/mL glutathione reductase, 0.1 mL of 15 mmol disodium 
salt of EDTA, 0.1 mL of 3 mmol reduced NADPH and an appropriate amount of tissue supernatant to 
a final volume of 3.0 mL. The reaction was started by addition of 0.1 mL of 7.5 mmol H2O2. The rate 
of  change  of  absorbance  during  the  conversion  of  NADPH  to  NADP
+  was  recorded 
spectrophotometerically at 340 nm for 3 min. GSH-Px activity was expressed as μmol of NADPH 
oxidized to NADP
+ min
−1 (mg
−1 protein) using an extinction coefficient (6.22 mM
−1· cm
−1) for NADPH. 
Protein content of the samples was determined by the Biuret method of Gornall et al. [56]. 
Glutathione reductase activity was assayed as described by Calberg and Mannervik [57], with some 
modifications, by measuring the oxidation of NADPH at 340 nm. The reaction mixture consisted of 
0.1 M sodium phosphate buffer (pH 7.5), 1 mM EDTA, 0.63 mM NADPH and 0.15 mM GSSG. Int. J. Mol. Sci. 2012, 13  5580 
 
 
4.5. Statistical Analysis 
Data  was  statistically  evaluated  using  one-way  ANOVA  in  SPSS  for  Windows  (version  11.5;  
SPSS Inc.: Chicago, IL, USA, 2002) installed computer. The values were considered significant when 
(P < 0.05). 
5. Conclusions 
Mice implanted with S180 sarcoma showed a significant increase in serum AST, ALT and ALP 
activities, liver MDA level, decrease in serum WBC, TP, ALB, A/G, TNF-α and IFN-γ, and liver GSH, 
SOD, CAT, GSH-Px and GR activities. This indicated that in hepatocarcinoma mice, liver function, 
and immunity activity have been greatly weakened and decreased. In addition, oxidative injury has 
been increased with decreased antioxidant enzymes activity. Twenty days of tea polyphenol treatment 
significantly decreased serum AST, ALT and ALP activities, liver MDA level, increase serum WBC, 
TP, ALB, A/G, TNF-α and IFN-γ, and liver GSH, SOD, CAT, GSH-Px and GR activities. These 
results  showed  that  tea  polyphenol  can  improve  liver  function,  and  immunity  activity,  decrease 
oxidative injury in hepatocarcinoma mice implanted with S180 sarcoma. Our present work indicated 
that tea polyphenol has a potential liver protection effect. It will be our necessary work in the future to 
test  pharmacological  function  of  individual  components  in  the  tea  polyphenol  in  hepatocellular 
carcinoma animals. 
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